Fig. 6

Effect of methylprednisolone on HBV-DNA and indicators of liver function. No significant difference in serum HBV DNA level was observed between the two groups (a). Serum bilirubin was significantly lower on days 3 and 7 (b); PTA was higher on days 3, 7, 10, 14, 28, and 60 (c); and INR was lower on days 7 and 10 (d) in methylprednisolone group than control group. Error bars: ± 1 SD, *P < 0.05; **P < 0.01. e Adverse events during treatment